These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 11397878)
1. Expression of 11 beta-hydroxysteroid dehydrogenase isoenzymes in the human pituitary: induction of the type 2 enzyme in corticotropinomas and other pituitary tumors. Korbonits M; Bujalska I; Shimojo M; Nobes J; Jordan S; Grossman AB; Stewart PM J Clin Endocrinol Metab; 2001 Jun; 86(6):2728-33. PubMed ID: 11397878 [TBL] [Abstract][Full Text] [Related]
2. Abnormal expression of 11 beta-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas: a prereceptor determinant of pituitary cell proliferation. Rabbitt EH; Ayuk J; Boelaert K; Sheppard MC; Hewison M; Stewart PM; Gittoes NJ Oncogene; 2003 Mar; 22(11):1663-7. PubMed ID: 12642869 [TBL] [Abstract][Full Text] [Related]
3. Expression and putative role of 11 beta-hydroxysteroid dehydrogenase isozymes within the human eye. Rauz S; Walker EA; Shackleton CH; Hewison M; Murray PI; Stewart PM Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2037-42. PubMed ID: 11481269 [TBL] [Abstract][Full Text] [Related]
4. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors. Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037 [TBL] [Abstract][Full Text] [Related]
5. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors. Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675 [TBL] [Abstract][Full Text] [Related]
6. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas. Morris DG; Kola B; Borboli N; Kaltsas GA; Gueorguiev M; McNicol AM; Ferrier R; Jones TH; Baldeweg S; Powell M; Czirják S; Hanzély Z; Johansson JO; Korbonits M; Grossman AB J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of 11beta-hydroxysteroid dehydrogenase eliminates impaired glucocorticoid suppression and induces apoptosis in corticotroph tumor cells. Nigawara T; Iwasaki Y; Asai M; Yoshida M; Kambayashi M; Sashinami H; Hashimoto K; Suda T Endocrinology; 2006 Feb; 147(2):769-72. PubMed ID: 16254034 [TBL] [Abstract][Full Text] [Related]
8. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease. Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046 [TBL] [Abstract][Full Text] [Related]
9. Type 2 11 beta-hydroxysteroid dehydrogenase in foetal and adult life. Stewart PM; Whorwood CB; Mason JI J Steroid Biochem Mol Biol; 1995 Dec; 55(5-6):465-71. PubMed ID: 8547171 [TBL] [Abstract][Full Text] [Related]
10. A switch in dehydrogenase to reductase activity of 11 beta-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells. Bujalska IJ; Walker EA; Hewison M; Stewart PM J Clin Endocrinol Metab; 2002 Mar; 87(3):1205-10. PubMed ID: 11889189 [TBL] [Abstract][Full Text] [Related]
11. Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation. Cooper MS; Bujalska I; Rabbitt E; Walker EA; Bland R; Sheppard MC; Hewison M; Stewart PM J Bone Miner Res; 2001 Jun; 16(6):1037-44. PubMed ID: 11393780 [TBL] [Abstract][Full Text] [Related]
12. Human 11 beta-hydroxysteroid dehydrogenase: studies on the stably transfected isoforms and localization of the type 2 isozyme within renal tissue. Bujalska I; Shimojo M; Howie A; Stewart PM Steroids; 1997 Jan; 62(1):77-82. PubMed ID: 9029719 [TBL] [Abstract][Full Text] [Related]
13. Coexpression of galanin and adrenocorticotropic hormone in human pituitary and pituitary adenomas. Hsu DW; Hooi SC; Hedley-Whyte ET; Strauss RM; Kaplan LM Am J Pathol; 1991 Apr; 138(4):897-909. PubMed ID: 1707237 [TBL] [Abstract][Full Text] [Related]
15. Differential expression of 11 beta-hydroxysteroid dehydrogenase types 1 and 2 in human placenta and fetal membranes. Sun K; Yang K; Challis JR J Clin Endocrinol Metab; 1997 Jan; 82(1):300-5. PubMed ID: 8989277 [TBL] [Abstract][Full Text] [Related]
16. Expression of 11beta-hydroxysteroid dehydrogenase type 2 in an ACTH-producing small cell lung cancer. Parks LL; Turney MK; Gaitan D; Kovacs WJ J Steroid Biochem Mol Biol; 1998 Nov; 67(4):341-6. PubMed ID: 9883991 [TBL] [Abstract][Full Text] [Related]
19. 11 beta-Hydroxysteroid dehydrogenase type II in the human endometrium: localization and activity during the menstrual cycle. Smith RE; Salamonsen LA; Komesaroff PA; Li KX; Myles KM; Lawrence M; Krozowski Z J Clin Endocrinol Metab; 1997 Dec; 82(12):4252-7. PubMed ID: 9398749 [TBL] [Abstract][Full Text] [Related]
20. Ghrelin is produced by and directly activates corticotrope cells from adrenocorticotropin-secreting adenomas. Martínez-Fuentes AJ; Moreno-Fernández J; Vázquez-Martínez R; Durán-Prado M; de la Riva A; Tena-Sempere M; Diéguez C; Jiménez-Reina L; Webb SM; Pumar A; Leal-Cerro A; Benito-López P; Malagón MM; Castaño JP J Clin Endocrinol Metab; 2006 Jun; 91(6):2225-31. PubMed ID: 16551736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]